Form 144 uniQure N.V. Filed by: Potts Jeannette

Go back to Form 144 uniQure N.V. Filed by: Potts Jeannette

uniQure BV (QURE) PT Raised to $71 at Stifel

June 17, 2026 9:31 AM EDT

Stifel analyst Paul Matteis raised the price target on uniQure BV (NASDAQ: QURE) to $71.00 (from $28.00) while maintaining a Buy rating.

The analyst comments "We're reiterating our Buy rating on QURE and raising our TP to $71, on the back of a positive and welcome surprise around FDA's ~180 on the regulatory path for AMT-130 (LINK). Bottom line: we now model a slightly greater than 50%... More